Findings

What do systematic reviews say?

1 questions · 1 findings · 1 reviews · Gut

No studies found 0 · 0%GRADE not reported 0 · 0%Very low 1 · 100%Low 0 · 0%Moderate 0 · 0%High 0 · 0%

Progression‐free survival · people with advanced gastric cancer

It is very uncertain whether capecitabine changes progression‐free survival compared with 5‐FU‐containing regimens (very low certainty).

1 finding from 1 review

Chemotherapy for advanced gastric cancer 2017 · Cochrane Headline outcomes only
HR 0.98 [0.77, 1.23]
4 studies · 647 participants
Very low